Loading chat...
HI SB967
Bill
Status
Introduced
1/17/2025
Primary Sponsor
Kurt Fevella
Click for details
AI Summary
- Mandates Medicaid and private health insurance coverage for intravenous ketamine therapy to treat depression beginning January 1, 2026, with coverage percentage to be determined
- Requires qualifying patients to be determined by licensed psychiatrists, medical doctors, or other authorized medical professionals who can prescribe ketamine
- Applies coverage requirements to individual and group accident, health, and sickness insurance policies, hospital and medical service plan contracts, and health maintenance organizations
- Appropriates unspecified general fund amounts for fiscal years 2025-2026 and 2026-2027 to the Department of Human Services for Medicaid coverage costs
- Medicaid provisions take effect upon approval of the Hawaii Medicaid state plan by the Centers for Medicare and Medicaid Services; other provisions take effect July 1, 2025
Legislative Description
Relating To Health.
Medicaid
Last Action
The committee on HHS deferred the measure.
2/6/2026
Committee Referrals
Health and Human Services1/23/2025
Full Bill Text
No bill text available